Essex Private Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,364
Closed -$575K 50
2021
Q4
$575K Sell
3,364
-499
-13% -$81.7K 0.49% 37
2021
Q3
$624K Sell
3,863
-154
-4% -$26.3K 0.57% 32
2021
Q2
$662K Buy
4,017
+1
+0% +$166 0.6% 33
2021
Q1
$660K Sell
4,016
-293
-7% -$47.4K 0.63% 31
2020
Q4
$678K Sell
4,309
-99
-2% -$14.6K 0.66% 32
2020
Q3
$656K Sell
4,408
-45
-1% -$6.66K 0.68% 30
2020
Q2
$626K Sell
4,453
-11
-0.2% -$1.6K 0.73% 30
2020
Q1
$585K Buy
4,464
+235
+6% +$33.3K 0.76% 28
2019
Q4
$616K Buy
+4,229
New +$574K 0.62% 32

Other funds holding JNJ

Essex Private Wealth Management's JNJ Position: Q1 2022 in Review

Essex Private Wealth Management sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 3,364 shares — an estimated $575K sold.

Essex Private Wealth Management first reported a position in JNJ in Q4 2019 and held it in 9 quarters. The position peaked at $678K in Q4 2020. 3,677 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • Essex Private Wealth Management reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
  • Essex Private Wealth Management sold 3,364 Johnson & Johnson shares in Q1 2022, an estimated $575K.
  • Essex Private Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 9 quarters.
  • Essex Private Wealth Management's Johnson & Johnson position peaked at $678K in Q4 2020.
  • 3,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Essex Private Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.